Nuo Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Nuo Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • Nuo Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $41.3M, a 0.91% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $41.3M -$381K -0.91% Dec 31, 2023 10-K 2024-04-19
Q4 2022 $41.6M +$1.59M +3.97% Dec 31, 2022 10-K 2024-04-19
Q4 2021 $40M +$24.6K +0.06% Dec 31, 2021 10-K 2023-04-17
Q4 2020 $40M +$24.2K +0.06% Dec 31, 2020 10-K 2022-04-15
Q4 2019 $40M +$311K +0.78% Dec 31, 2019 10-K 2022-04-15
Q4 2018 $39.7M +$405K +1.03% Dec 31, 2018 10-K 2019-04-16
Q4 2017 $39.3M -$13.6M -25.7% Dec 31, 2017 10-K 2019-04-16
Q4 2016 $52.9M -$19.3M -26.7% Dec 31, 2016 10-K 2018-04-16
Q1 2016 $72.2M May 4, 2016 10-K 2017-03-29
Q4 2015 $72.2M +$32.6M +82.4% Dec 31, 2015 10-K 2016-10-24
Q4 2014 $39.6M -$2.5M -5.94% Dec 31, 2014 10-K 2016-10-24
Q4 2013 $42.1M +$3.65M +9.5% Dec 31, 2013 10-K 2015-03-31
Q4 2012 $38.4M +$18.7M +95% Dec 31, 2012 10-K 2015-03-31
Q4 2011 $19.7M +$1.37M +7.45% Dec 31, 2011 10-K 2014-03-31
Q4 2010 $18.3M Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.